stp Resolved · high auto-curated
H37Rv Rv2333c · MTBC0 mtbc0_002483 ·
523 aa ·
2631457–2633071 MTBC0
(-) ·
RefSeq NP_216849.1
⚠ The ancestral MTBC0 locus is annotated as a pseudogene by its own
source: mtbc0_002483 carries pseudo=true in the PGAP annotation of
the MTBC0 reconstruction, with the reason given as frameshifted.
Re-translating the ancestral region confirms
1 internal stop codon,
the first at residue 524 — which is where the 523 aa protein
served here ends, against 537 aa for the H37Rv product. The frameshift is the cause and the stop its downstream
consequence, so the two are not interchangeable.
Measured, not assumed — this disruption is ancestral.
146 of 149 outgroup
M. canettii strains stop at the same point, and so do
76 % of the L6 panel. The ancestral reconstruction is therefore
right to carry the defect here: it is an ancestral state, not a reconstruction artefact.
Source: MTBC0v1.1_PGAP_annot.gff, Harrison et al. 2024 (imputed MTBC ancestor); polarisation measured in phase244 (P51.2q, 2026-09-18). Polarisation method: the CDS of each strain is rebuilt from its own called variants and translated to the first REAL stop codon, past the annotated bound; a strain counts here when its product stops where the ancestral protein stops (± 5 aa), which is the SAME defect rather than merely another one. No single strain is read on its own (an uncalled site is not a confirmed reference allele), only the fraction over a panel.
The structural and functional layers below were computed on the translated (truncated) sequence.
Genomic neighbourhood (genome browser)
Open in full genome browser →This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.
Annotation: from legacy to revised
| Legacy (H37Rv / Mycobrowser) | multidrug resistance protein |
|---|---|
| MTBC0 PGAP re-annotation | multidrug resistance protein Stp |
| Revised (this work) | Multidrug resistance protein Stp. Pfam: MFS_1 (PF07690.22), Sugar_tr (PF00083.31). |
| Functional category (TubercuList) | cell wall and cell processes |
Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.
In the literature (TB corpus sweep) 15 publications
15 TB publications mention this gene. 15 publications discuss this gene (count verified against title and abstract text). Queried separately, 17 records carry a M. tuberculosis context and 2 a non-TB mycobacterial context (species named in the 2-record verified sample: M. smegmatis (2)). The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.
| Publication | Date |
|---|---|
| Quality Evaluation of Shexiang Tongxin Dropping Pill Based on HPLC Fingerprints Combined with HPLC-Q-TOF-MS/MS Method. doi:10.1093/chromsci/bmae015 | 2024 |
| TB treatment non-adherence in São Tomé and Príncipe. doi:10.5588/pha.22.0040 | 2022 |
| Mechanistic insights into the antimycobacterial action of unani formulation, Qurs Sartan Kafoori. doi:10.1016/j.jtcme.2021.07.009 | 2022 |
| Lateral Flow Genochromatographic Strip for Naked-Eye Detection of Mycobacterium Tuberculosis PCR Products with Gold Nanoparticles as a Reporter. doi:10.31661/jbpe.v0i0.1912-1018 | 2020 |
| Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.jgar.2019.01.003 | 2019 |
3 records returned by the alias sweep (a separate sweep from the 15 above; both are shown, neither is exhaustive)
Searched as: Rv2333c, Mb2361c, MMAR_3642, MSMEG_3405, MAB_0945
— each in conjunction with a mycobacterial context term. Swept 2026-09-07.
| Publication | Journal | Year |
|---|---|---|
| Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria. doi:10.1016/j.bmc.2018.08.034 | Bioorg Med Chem | 2018 |
| [A new method for the disruption of cell walls of gram-positive bacteria and mycobacteria on the point of nucleic acid extraction: sand method]. doi:10.5578/mb.10685 | Mikrobiyol Bul | 2016 |
| Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. doi:10.1093/jac/dkl510 names it | J Antimicrob Chemother | 2007 |
Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.
This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.
Genomic-neighbour overlap (structural caveat) antiparallel · 3 % of gene
| Neighbour | mez (Rv2332, + strand) |
|---|---|
| Overlap | 47 bp, 3 % of this gene's length |
antiparallel overlap: this gene may inherit essentiality/conservation signal from its neighbour through shared TA sites or promoter constraint, without any protein of its own being produced (cf. Rv2438A/nadE) Signals attributed to this gene (Tn-seq essentiality via shared TA sites, conservation via promoter constraint) should be cross-checked against the neighbour before being read as its own. P20.1, derived from GFF3 gene coordinates, 2026-08-03.
CRISPRi vulnerability
Vulnerability index 1.16 (95% CI -0.43 to 3.59). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.
Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).
Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.298 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=18 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.
Legacy record & comparison (Mycobrowser)
| Mycobrowser function | Involved in transport of drug across the membrane (export) |
|---|
The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.
Orthologues (reciprocal best hits across mycobacteria)
| M. bovis |
Mb2361c
· 99.6% identity |
|---|---|
| M. marinum |
MMAR_3642
· 80.2% identity |
| M. smegmatis |
MSMEG_3405
· 31.2% identity |
| M. orygis |
RJtmp_002414
· 99.8% identity |
| M. abscessus |
MAB_0945
· 36.1% identity |
Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.
Curated reference (UniProt)
| UniProt |
P9WG91
SwissProt · reviewed
· Evidence at protein level
|
|---|---|
| UniProt name | Multidrug resistance protein Stp |
| Curated function | Contributes to spectinomycin and tetracycline resistance. |
Functional vocabulary (eggNOG-mapper, orthology transfer)
| COG category |
E Amino acid transport and metabolismG Carbohydrate transport and metabolismP Inorganic ion transport and metabolism
|
|---|---|
| eggNOG description | Major facilitator superfamily |
| Orthologous group | COG0477 |
Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.
Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29) pseudogene candidate
| pN/pS | 1.987 · diversifying/relaxed |
|---|---|
| Polymorphic sites (≥ 0.1% of strains) | 2 synonymous, 10 missense, 1 nonsense, 2 frameshift |
| Disruption | 3 distinct premature-stop/frameshift site(s); most common in 28.77% of strains (41021) · clonal |
| Which clade carries which site (attribution) |
CONVERGENCE inter-clades (sites différents) — Bovis, Caprae_La2, L1, L5, L6, L7, L9, L_1, La4, Microti, Orygis_La3, Pinnipedii, Suricattae;
union over all sites: 42 399
strains (the count above is a maximum over sites, not a union).
|
Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.
pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.
Outgroup conservation (beyond the MTBC) Actinomycetia
| M. canettii dN/dS (deep-divergence selection) |
undefined (dS = 0) (low power)
· 2 consensus substitution(s) · 1 canettii-fixed disruption low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable; carries 1 M. canettii-clade-fixed disruptive substitution(s) (candidate lineage-specific pseudogenisation — cross-check the intra-MTBC pseudogene layer) Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table). |
|---|---|
| Genus-wide presence (~53 non-MTBC Mycobacterium) |
present in 53/53 (100%) · mean identity 42.2%
· 4/4 closest MTBAP relatives conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation |
| Phylostratum (deepest detected homolog) |
MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria detected in 9/13 non-Mycobacterium reference genomes (down to Actinomycetia) · mean identity 35.6% detected across the class Actinomycetia (beyond Corynebacteriales) but not outside the phylum — an Actinobacteria-level ancient gene |
Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.
Essentiality (transposon mutagenesis)
| DeJesus 2017 call | NE · non-essential |
|---|---|
| What the call means | non-essential |
| TA sites (Himar1) |
21 in the ORF —
0 in the essential state,
0 growth-defect,
21 non-essential,
0 growth-advantage.
Saturation 1.000,
mean read count 218.285714286.
A region of the protein devoid of TA sites is invisible to this assay: nothing can be
inferred about it, in either direction.
18 of these 21 sites are exclusively this ORF's; Measured, not hypothetical: 3 of this ORF's 21 TA sites lie inside Rv2332 (3 sites), leaving 18 sites that are exclusively its own. A transposon insertion cannot be assigned to one reading frame rather than the other, so the essentiality call rests on those 18 exclusive sites. |
Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.
Mutant phenotypes (conditional Tn-seq, MtbTnDB)
| Condition | log2FC | q | Effect |
|---|---|---|---|
| altered fitness under Isoniazid (drug exposure) | +1.98 | 0.03 | disruption advantageous |
Conditional fitness of transposon-disruption mutants across 1 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.
Proteomics (mass spectrometry) detected
| MS detection | detected in 3 of 16 independent MS datasets |
|---|---|
| Integrated abundance | 0.27 ppm · rank 3412/3519 (3.1th percentile) |
Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.
Predicted localisation (DeepTMHMM + lipobox)
| Prediction | predicted membrane protein (14 TM helixes) |
|---|---|
| DeepTMHMM class | TM |
| TM helices (DeepTMHMM) | 14 |
Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.
Physico-chemical properties (computed, ProtParam)
| Length | 523 aa |
|---|---|
| Molecular weight | 55.7 kDa |
| Theoretical pI | 8.13 |
| GRAVY | 0.724 (hydrophobic) |
| Aliphatic index | 120.0 |
| Aromaticity | 0.08 |
| Instability index | 39.4 (stable) |
Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.
Domains (Pfam, hmmscan --cut_ga)
| Pfam | Accession | i-Evalue | Residues | Description |
|---|---|---|---|---|
MFS_1 | PF07690.22 | 1.6e-57 | 14–403 | Major Facilitator Superfamily |
Sugar_tr | PF00083.31 | 1.4e-07 | 45–186 | Sugar (and other) transporter |
3D structure (interactive — Mol*/pdbe-molstar)
No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 83.6, confident), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.
Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 83.6
| PDB hit | prob | TM (aln) | TM (query) | TM (target) | Seq. id. | Cov. q / t | E-value | Description |
|---|---|---|---|---|---|---|---|---|
8ufd-assembly1_A |
1.00 | 0.78 | 0.70 | 0.78 | 26% | 92% / 97% | 1.0e-19 sig | 8ufd-assembly1_A Multidrug efflux pump MtEfpA bound with inhibitor BRD8000.3 |
7y58-assembly1_A |
1.00 | 0.76 | 0.73 | 0.76 | 25% | 92% / 96% | 9.2e-20 sig | 7y58-assembly1_A CryoEM structure of QacA (D411N), an antibacterial efflux transporter from Staphylococcus aureus |
8ufe-assembly1_A |
1.00 | 0.77 | 0.69 | 0.77 | 26% | 91% / 97% | 1.6e-18 sig | 8ufe-assembly1_A Multidrug efflux pump EfpA from mycobacterium smegmatis |
8pnl-assembly1_A |
1.00 | 0.75 | 0.68 | 0.75 | 21% | 93% / 100% | 9.9e-17 sig | 8pnl-assembly1_A Outward-open conformation of a Major Facilitator Superfamily (MFS) transporter MHAS2168, a homologue of Rv1410 from M. tuberculosis, in complex with an alpaca nanobody |
8pnl-assembly2_C |
1.00 | 0.71 | 0.65 | 0.71 | 20% | 92% / 99% | 1.6e-15 sig | 8pnl-assembly2_C Outward-open conformation of a Major Facilitator Superfamily (MFS) transporter MHAS2168, a homologue of Rv1410 from M. tuberculosis, in complex with an alpaca nanobody |
Foldseek search of the AlphaFold DB model (mean pLDDT 83.6, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.
Genomic context (neighbours & predicted operon)
| Upstream (5' on genome) | mez (+ strand, -47 bp gap) |
|---|---|
| Downstream (3' on genome) | cysK1 (+ strand, 474 bp gap) |
Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).
Published operon evidence (two independent sources)
| Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) | no multi-gene operon predicted (singleton) |
|---|---|
| REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2395) |
expressed, no multi-gene operon (exponential phase, coverage 12.65)
not expressed (stationary phase) — agrees with the distance heuristic above |
Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.
Transcriptional regulation (signed TRN: ChIP-seq + TFOE)
| Regulated by (1 TF) |
tcrA (represses)
|
|---|
Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.
Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.
Functional interaction network (STRING v12, guilt-by-association)
Explore full network →Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.
All 3 partner(s) at medium confidence are shown. None rests on an interaction measured in M. tuberculosis itself.
| Partner | Product | Score | No text-mining | Channels (≥400) |
|---|---|---|---|---|
Rv1410c paralog |
aminoglycosides/tetracycline-transport integral membrane protein | 446 | 345 | |
Rv1776c |
transcriptional regulator | 469 | 64 | textmining:457 |
Rv0134 ephF |
epoxide hydrolase EphF | 425 | 49 | textmining:421 |
STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.
Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.
Evidence
- Legacy H37Rv annotation: multidrug resistance protein
- MTBC0 PGAP product: multidrug resistance protein Stp
- Pfam (hmmscan --cut_ga): MFS_1 PF07690.22 (E=2e-57), Sugar_tr PF00083.31 (E=1e-07)
- (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)
Sources
- Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
- Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216849.1)
- Domains: Pfam-A via hmmscan --cut_ga — MFS_1 (PF07690.22), Sugar_tr (PF00083.31)
- Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
- Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021,
doi:10.1093/molbev/msab293), eggNOG 5.0 DB
(Huerta-Cepas et al. 2019) — OG
COG0477 - Curated reference: UniProt P9WG91 (SwissProt, reviewed; Evidence at protein level)
- Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
- Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 83.6)
- Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 3 functional partner(s)
- Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
- Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
- Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
- Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
- Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
- Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
- Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
- Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
- Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
- Primary literature: none located yet; annotation rests on the domain/homology sources above.
Ancestral MTBC0 protein sequence
>mtbc0_002483|Rv2333c|stp MNRTQLLTLIATGLGLFMIFLDALIVNVALPDIQRSFAVGEDGLQWVVASYSLGMAVFIMSAATLADLYGRRRWYLIGVSLFTLGSIACGLAPSIAVLTTARGAQGLGAAAVSVTSLALVSAAFPEAKEKARAIGIWTAIASIGTTTGPTLGGLLVDQWGWRSIFYVNLPMGALVLFLTLCYVEESCNERARRFDLSGQLLFIVAVGALVYAVIEGPQIGWTSVQTIVMLWTAAVGCALFVWLERRSSNPMMDLTLFRDTSYALAIATICTVFFAVYGMLLLTTQFLQNVRGYTPSVTGLMILPFSAAVAIVSPLVGHLVGRIGARVPILAGLCMLMLGLLMLIFSEHRSSALVLVGLGLCGSGVALCLTPITTVAMTAVPAERAGMASGIMSAQRAIGSTIGFAVLGSVLAAWLSATLEPHLERAVPDPVQRHVLAEIIIDSANPRAHVGGIVPRRHIEHRDPVAIAEEDFIEGIRVALLVATATLAVVFLAGWRWFPRDVHTAGSDAKREAAYSDDRRVRG
Spot an error? Suggest an improvement
Found a mistake, a missing reference, or have a better functional hypothesis for stp? Report it below — the message is emailed to the maintainer with this gene's details, reviewed by hand (no automatic edits).
Prefer email directly? ✉ Email a correction about stp